0001181431-12-039587.txt : 20120703
0001181431-12-039587.hdr.sgml : 20120703
20120703210648
ACCESSION NUMBER: 0001181431-12-039587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120702
FILED AS OF DATE: 20120703
DATE AS OF CHANGE: 20120703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMahon Gerald PhD
CENTRAL INDEX KEY: 0001290747
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 12946818
MAIL ADDRESS:
STREET 1: 300 ELLIOTT AVENUE WEST
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98119-4114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OXIGENE INC
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
rrd350350.xml
FORM 4
X0306
4
2012-07-02
0
0000908259
OXIGENE INC
OXGN
0001290747
McMahon Gerald PhD
C/O: OXIGENE, INC.
701 GATEWAY BLVD., SUITE 210
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
0.551
2012-07-02
4
A
0
50500
0
A
2012-07-02
2018-07-02
Common Stock
50500
50500
D
Dr. McMahon elected to receive options to purchase shares of OXiGENE, Inc. common stock (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Directors services to be provided during the second six months of 2012.
The Stock Options were fully vested as of the grant date.
Megan N. Gates, Attorney-in-fact
2012-07-03